Long-term outcome of kidney transplantation in a patient with coexisting lipoprotein glomerulopathy and fibrillary glomerulonephritis

被引：5

作者：

Cheung, Chi Yuen ^{[1
]}

Chan, Angel O. K. ^{[2
]}

Chan, Gordon P. T. ^{[3
]}

Iu, Heidi Y. P. ^{[3
]}

Shek, Chi Chung ^{[3
]}

Chau, Ka Foon ^{[1
]}

机构：

[1] Queen Elizabeth Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China

[2] Queen Mary Hosp, Dept Pathol & Clin Biochem, Hong Kong, Hong Kong, Peoples R China

[3] Queen Elizabeth Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China

来源：

CLINICAL KIDNEY JOURNAL | 2014年 / 7卷 / 04期

关键词：

fibrillary glomerulonephritis; kidney transplant; lipoprotein glomerulopathy;

D O I：

10.1093/ckj/sfu058

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Both lipoprotein glomerulopathy (LPG) and fibrillary glomerulonephritis (FGN) are rare causes of end-stage renal disease (ESRD), and the literature concerning the outcome of kidney transplant in patients with LPG or FGN is scarce. We report a patient who suffered from ESRD with coexisting FGN and LPG and received deceased kidney transplant > 10 years ago did not reveal any clinical features of disease recurrence during follow-up. Our case shows that the prognosis of patients with LPG component who received kidney transplant can be good. Kidney transplantation remains a viable therapeutic option for patients with ESRD secondary to FGN with LPG.

引用

页码：396 / 398

页数：3

共 14 条

[1] Recurrence of lipoprotein glomerulopathy after renal transplantation [J].

Andrews, PA ;

ODonnell, PJ ;

Dilly, SA ;

Snowden, SA ;

Bewick, M .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (11) :2442-2444

[2] Long-term outcome of kidney transplantation in patients with fibrillary glomerulonephritis or monoclonal gammopathy with fibrillary deposits [J].

Czarnecki, Peter G. ;

Lager, Donna J. ;

Leung, Nelson ;

Dispenzieri, Angela ;

Cosio, Fernando G. ;

Fervenza, Fernando C. .

KIDNEY INTERNATIONAL, 2009, 75 (04) :420-427

[3] A rare cause of posttransplantation nephrotic syndrome [J].

Foster, K ;

Matsunaga, A ;

Matalon, R ;

Saito, T ;

Gallo, G ;

D'Agati, V ;

Stokes, MB .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (06) :1132-1138

[4] Common Apolipoprotein E Gene Mutations Contribute to Lipoprotein Glomerulopathy in China [J].

Han, Jia ;

Pan, Yongli ;

Chen, Yuqing ;

Li, Xia ;

Xing, Guangqun ;

Shi, Junhua ;

Hou, Ping ;

Zhang, Hong ;

Wang, Haiyan .

NEPHRON CLINICAL PRACTICE, 2010, 114 (04) :C260-C267

[5] Association of a novel 3-amino acid deletion mutation of apolipoprotein E (Apo E Tokyo) with lipoprotein glomerulopathy [J].

Konishi, K ;

Saruta, T ;

Kuramochi, S ;

Oikawa, S ;

Saito, T ;

Han, H ;

Matsunaga, A ;

Sasaki, J .

NEPHRON, 1999, 83 (03) :214-218

[6] A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy [J].

Matsunaga, A ;

Sasaki, J ;

Komatsu, T ;

Kanatsu, K ;

Tsuji, E ;

Moriyama, K ;

Koga, T ;

Arakawa, K ;

Oikawa, S ;

Saito, T ;

Kita, T ;

Doi, T .

KIDNEY INTERNATIONAL, 1999, 56 (02) :421-427

[7] Recurrence of fibrillary glomerulonephritis in a renal transplant recipient [J].

Mitwalli, Ahmed ;

Shah, Iqbal ;

Hammad, Durdana ;

Kafoury, Hala .

INTERNATIONAL UROLOGY AND NEPHROLOGY, 2013, 45 (05) :1527-1532

[8]

Miyata T, 1999, J AM SOC NEPHROL, V10, P1590

[9] Lipoprotein glomerulopathy: a new cause of nephrotic syndrome after renal transplantation [J].

Mourad, G ;

Djamali, A ;

Turc-Baron, C ;

Cristol, JP .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (05) :1292-1294

[10]

Oikawa S, 1997, J AM SOC NEPHROL, V8, P820

← 1 2 →